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ABSTRACT
Purpose Cerebral misery perfusion (CMP) is a condition 
where cerebral autoregulatory capacity is exhausted, 
and cerebral blood supply in insufficient to meet 
metabolic demand. We present an educational review 
of this important condition, which has a range of clinical 
manifestations.
Method A non-systematic review of published literature 
was undertaken on CMP and major cerebral artery 
occlusive disease, using Pubmed and Sciencedirect.
Findings Patients with CMP may present with strokes 
in watershed territories, collapses and transient 
ischaemic attacks or episodic movements associated 
with an orthostatic component. While positron emission 
tomography is the gold standard investigation for misery 
perfusion, advanced MRI is being increasingly used as an 
alternative investigation modality. The presence of CMP 
increases the risk of strokes. In addition to the devastating 
effect of stroke, there is accumulating evidence of 
impaired cognition and quality of life with carotid occlusive 
disease (COD) and misery perfusion. The evidence for 
revascularisation in the setting of complete carotid 
occlusion is weak. Medical management constitutes 
careful blood pressure management while addressing 
other vascular risk factors.
Discussion The evidence for the management of 
patients with COD and CMP is discussed, together with 
recommendations based on our local experience. In this 
review, we focus on misery perfusion due to COD.
Conclusion Patients with CMP and COD may present with 
a wide-ranging clinical phenotype and therefore to many 
specialties. Early identification of patients with misery 
perfusion may allow appropriate management and focus 
on strategies to maintain or improve cerebral blood flow, 
while avoiding potentially harmful treatment.
BACKGROUND, PATHOGENESIS AND 
EPIDEMIOLOGY
Cerebral misery perfusion (CMP) is a 
condition where regional cerebral blood 
flow (rCBF) is reduced relative to the regional 
metabolic demand for oxygen, and is defined 
by increased tissue oxygen extraction frac-
tion (OEF) on positron emission tomography 
(PET).
Atherosclerosis of the internal carotid 
artery or the middle cerebral artery causing 
occlusive disease is the most common cause of 
CMP. Less common causes include dissection, 
cardiac embolism, radiation vasculopathy, 
vasculitis and other chronic inflammatory 
conditions such as Takayasu’s aortoarteritis. 
The occlusive process leads to reduced CBF in 
the distal arterial system, leading to haemody-
namic impairment with disease progression. 
Table 1 illustrates the stages of cerebral 
haemodynamic impairment and the patho-
physiology behind the development of CMP. 
Most of our understanding of CMP comes 
from studies looking at carotid occlusive 
disease (CAO), on which this review will focus.
Many patients with CAO remain asymp-
tomatic and therefore the true prevalence of 
asymptomatic CAO is unknown. When ‘symp-
tomatic’ (transient ischaemic attack (TIA) 
or stroke), the prevalence of CAO has been 
reported to be 6/100 000; however, the 
authors in the study felt that true prevalence 
was probably higher as many patients with 
transient symptoms may not have sought 
medical help.1 In addition to the above, the 
difficulty in ascertaining the epidemiology 
of CMP is compounded by the limited avail-
ability of diagnostic investigations such as 
PET, and the under-recognition of symptoms 
that may be attributed to CMP in day-to-day 
clinical practise.
CLINICAL AND RADIOLOGICAL FEATURES
People with CMP may present with a range 
of clinical manifestations such as collapses, 
strokes in watershed territories or with 
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Key Points
 ► Consider the diagnosis of CMP in patients with
 ► orthostatic TIA symptoms
 ► episodic limb-shaking
 ► watershed territory infarcts
 ► high-grade carotid steno-occlusive disease
 ► decrease in CBF with increased oxygen extraction 
distal to an occlusion
 ► Confirm diagnosis with imaging of carotids and PET/
MRI ASL
 ► Blood pressure should be lowered cautiously
 ► Consider revascularisation in selected individuals
 ► Address episodes of hypotension aggressively
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reversible neurological deficits resembling TIAs. The 
recognition of this condition enables appropriate 
management, with avoidance of unnecessary and poten-
tially harmful treatment. Several factors such as collateral 
blood supply, extent of haemodynamic impairment, 
contribution of posterior communicating arteries and 
rapidity of development of CAO determine the clinical 
phenotype (table 2). Chronic occlusions from progres-
sive atherosclerotic disease usually develop slowly and 
may allow for the formation of collaterals. Such occlu-
sions are usually asymptomatic and are often discovered 
incidentally on vascular imaging after a TIA or stroke. 
van Laar et al found that in functionally independent 
patients with symptomatic CAO, the ipsilateral middle 
cerebral and anterior cerebral arteries were supplied by 
the vertebrobasilar and contralateral internal carotid 
arteries, respectively.2
While strokes due to CAO may present with clinical 
features similar to those due to any other aetiology, 
certain distinctive radiological features suggest an under-
lying haemodynamic mechanism. Rosary-like infarction 
of the centrum semi-ovale (indicating internal watershed 
territory infarction) has been shown to be the most sensi-
tive marker for haemodynamic failure (figure 1 A,B and 
C).3
In patients with transient symptoms, a detailed history 
may reveal an underlying haemodynamic problem. 
Particular attention should be paid to symptoms provoked 
by standing up, exercise, postprandial or the recent 
commencement of antihypertensives. Rarely, patients 
present with transient repetitive involuntary movements 
in the limbs contralateral to the occluded internal carotid 
artery (ICA), called limb-shaking TIAs.4
Syncope and collapses may be caused by CMP.5 In our 
own experience, syncope was the presenting feature 
in 7 patients out of a case series of 204 patients, who 
were later found to have unilateral or bilateral CAO at 
Nottingham City Hospital. This was felt to have been 
an underestimation as many more patients had given a 
history of ‘collapses’, which in retrospect were probably 
syncopal episodes. In the same case series, nine patients 
presented with transient global amnesia; it is possible 
that the resultant cerebral ischaemia from CAO may be 
involved in the pathogenesis of this poorly understood 
condition.6
In addition to the increased OEF measured by PET, 
which has limited availability, there may be other ways to 
identify those patients with CAO, haemodynamic insuf-
ficiency and a higher stroke risk. Leptomeningeal and 
ophthalmic collateral circulation, watershed infarction, 
impaired vasoreactivity to acetazolamide and orthostatic 
limb-shaking were all noted to predict haemodynamic 
failure, increased OEF on PET and higher stroke risk.7 
Another study identified age, cerebral (rather than 
Table 1 Pathophysiology of cerebral misery perfusion and stages of cerebral haemodynamic impairment 
Stage 1
(cerebrovascular 
autoregulation)
Any fall in regional cerebral perfusion pressure (rCPP) is matched by a fall in regional 
cerebrovascular resistance (rCBR) in order to maintain regional cerebral blood flow (rCBF). This 
is accommodated by vasodilatation and an attendant increase in regional cerebral blood volume 
(rCBV). Oxygen extraction factor (OEF) remains constant.
Stage 2
(misery perfusion)
The capacity for compensatory vasodilatation is exceeded (rCVR becomes a constant) and rCBF 
therefore drops in tandem with rCPP. To meet their metabolic demands, neurons must ‘extract 
more oxygen’ from the passing blood—OEF increases.
Stage 3
(end-organ compromise)
If rCBF continues to fall to the extent that the brain can no longer compensate by increases 
in OEF, end-organ dysfunction occurs (transient ischaemic attack). If this situation persists, 
permanent end-organ damage (stroke) occurs.
Source: Reproduced from Gordon et al40 with permission.
Table 2 Clinical spectrum of carotid occlusive disease
Clinical presentation Features
Ischaemic stroke Especially ‘borderzone’ infarcts in anterior or posterior cortical watershed or in the deep 
internal watershed territories
Transient ischaemic attack Can be provoked by standing posture or new antihypertensive treatment
Limb-jerking Transient repetitive involuntary limb movements, which may be misdiagnosed as partial 
seizures (but with no Jacksonian march, no epileptiform activity on EEG and no improvement 
with anticonvulsants)4
Ocular symptoms Amaurosis fugax (complete loss of vision), or even unilateral blurred vision when looking at 
bright light or going from cold to warm surroundings (retinal claudication)41 42
Syncope Associated with standing posture but often with no drop in systemic blood pressure5
Cognitive impairment Gradual deterioration in memory and other cognitive facets43
Transient global amnesia Short-term loss of memory function with no other signs of impaired cognition6
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retinal) symptoms, limb-shaking TIAs at presentation, 
history of previous strokes and the presence of leptome-
ningeal collaterals as risk factors for recurrent stroke in 
patients with symptomatic CAO.8
INVESTIGATIONS
Doppler ultrasound (DU) is the usual initial imaging 
modality to look for disease of the extracranial ICA. It has 
the benefit of being cheap and non-invasive, with a diag-
nostic accuracy of 97% in identifying complete CAO.9 
Distinguishing between complete and near-occlusion can 
however be difficult: an important distinction to make, 
as revascularisation should be considered in patients with 
near occlusion. DU with the use of contrast improves the 
ability to distinguish between total and near-occlusion.10 
It is however operator dependent, and has a limited field 
of view that renders the evaluation of vessel course and 
tandem lesions difficult.
The ‘gold standard’ for the evaluation of CAO is digital 
subtraction angiography. But it is invasive and carries the 
risk of neurological complications. Multislice CT angiog-
raphy (figure 2A) has excellent correlation with catheter 
angiography in diagnosing complete versus near-occlu-
sion of the ICA, and if used in combination with DU averts 
the need for catheter angiography.11 12 Time-of-flight 
magnetic resonance (MR) angiogram (figure 2B) uses the 
movement of blood as endogenous contrast to measure 
the degree of stenosis. However, it is flow-dependent, and 
may overestimate the degree of carotid stenosis due to 
signal loss in areas of slow flow from severe steno-occlu-
sive disease. Gadolinium-enhanced MR angiogram is less 
susceptible to this, and has equivalent sensitivity to DU in 
diagnosing complete CAO, and is probably better than 
DU at identifying near-occlusion.13
The assessment of CBF is important when clinical and 
radiological features suggest haemodynamic impairment. 
PET remains the gold standard for assessing cerebral 
haemodynamics, but there are issues with high cost 
and concerns over methodology.14Transcranial Doppler 
(TCD) US, Xenon-CT and single-photon emission CT 
have all been used to assess cerebral haemodynamic 
status and vasoreactivity.15–17 However, TCD US is also 
operator-dependent and may not technically possible in 
some individuals, while CT-based techniques carry radia-
tion exposure. One advantage with TCD is the assessment 
of collateralisation, using the direction of flow in the 
anterior communicating and posterior communicating 
arteries.
In recent years, there has been particular interest in 
advanced MRI techniques. Arterial spin labelling (ASL) 
MRI uses radiofrequency pulses to non-invasively label 
water protons in blood, and can measure vasodilator 
capacity in symptomatic carotid stenosis.18 T2*-based 
blood oxygen level-dependent contrast (BOLD) MRI 
uses deoxyhaemoglobin as an indicator of OEF. Cere-
brovascular reactivity (CVR) can be quantified using 
hypercapnia BOLD MRI with good reproducibility.19 
The technique involves serial MR scans obtained during 
periods of normocapnia and hypercapnia. CVR maps are 
then obtained and cerebrovascular vasodilatory capacity 
can be assessed. An increase in the BOLD signal indicates 
cerebral vasodilatation, whereas loss of CO2-induced 
BOLD reactivity suggests maximum compensatory vaso-
dilatation. As BOLD MRI allows whole-brain imaging, it is 
possible to assess regional variations in CVR.
In spite of the recent developments in advanced MR 
techniques, PET has been the investigation of choice in 
major trials evaluating CMP and revascularisation tech-
niques (to be discussed later). There are however other 
complexities with PET imaging in addition to cost and 
unavailability. While the original definition of CMP was 
increased OEF, there has been much heterogeneity in 
what is considered to be CMP. Some investigators have 
used a hemispheric OEF ratio of >1.13 to define CMP 
(Carotid Occlusion Surgery Study (COSS) study), while 
others have included decreased CBF and decreased CBF/
CBV ratio in addition to increased OEF.20
PROGNOSIS AND OUTCOMES
Flaherty et al reported the risk of stroke in patients with 
symptomatic carotid occlusion to be 10% and 14%, at 1 
and 5 years, respectively. The same study also reported 
a mortality of 29% at 5 years.1 The risk of recurrent 
stroke in patients with symptomatic CAO is 2.4%–7% 
per year, and this rises significantly in the presence of 
Figure 1 (A) Diffusion-weighted MRI showing internal 
watershed infarcts. (B) T2-weighted MRI showing posterior 
cortical watershed infarction. (C) CT brain showing anterior 
cortical watershed infarct.
Figure 2 (A) CT angiogram showing bilateral internal carotid 
occlusive disease (CAO). (B) MR angiogram showing right 
internal CAO.
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haemodynamic impairment due to exhausted cerebrovas-
cular reserve.8 21–23 The ipsilateral ischaemic and all stroke 
risk was found to be higher in patients with CMP (17.1% 
and 26%, respectively), than those without CMP (3.1% 
and 9.2%, respectively).20 The stroke risk in patients 
without CMP decreased over time; however, there was no 
such reduction in stroke risk over time in patients with 
CMP. The presence of CMP and bilateral asymptomatic 
lacunar infarcts were significant independent predictors 
of future ipsilateral ischaemic strokes. The study included 
patients with middle cerebral and internal carotid artery 
occlusive disease, and a separate analysis of the two groups 
revealed that CMP was a predictor of recurrent ischaemic 
stroke in both.20
The ability of patients with CAO and CMP to lead 
normal lives may be impaired in other ways, separate 
from the devastating effect of stroke. There is now accu-
mulating evidence of impaired cognition and quality of 
life in patients with CAO.24 25 What is not known is the 
long-term effects of CAO and CMP on mood, level of 
function and disability. There is a need for high-quality 
research evaluating these specific domains in relation to 
revascularisation for patients with CAO.
MANAGEMENT
Revascularisation
An important first step is to distinguish between complete 
occlusion and near-occlusion. Symptomatic internal 
carotid artery near-occlusion presents a strong case for 
revascularisation through carotid endarterectomy (CEA) 
or carotid artery stenting (CAS), in order to reduce future 
stroke risk. While CAS in patients with near-occlusion can 
be effective in preventing stroke recurrence, there have 
been concerns with cerebral hyperperfusion syndrome 
(CHS) and postprocedure vascular events.26 There is of 
course a risk of CHS with any carotid revascularisation 
procedure, and this was in fact originally described after 
CEA. In older people, CAS is associated with increased 
stroke risk, whereas CEA has similar neurological 
outcomes in both the young and old but at the expense 
of increased mortality in the elderly.27
The evidence for revascularisation in the setting of 
complete occlusion is weak. Yasargil was the first to describe 
an anastomosis between superficial temporal artery and a 
branch of the middle cerebral artery (figure 3).28 While 
initially incorporated into clinical practice, bypass surgery 
was abandoned after publication of the initial extracrani-
al-intracranial (EC-IC) bypass surgery, which showed no 
benefit with surgery over best medical treatment.29 The 
study was however criticised for poor design and imple-
mentation. Additionally, it was hypothesised that surgery 
should only be offered to patients with haemodynamic 
impairment.22
The COSS and Japanese EC-IC Bypass Trial (JET) were 
set up to answer this question. JET showed benefit at 2 
years (second interim analysis) for patients undergoing 
EC-IC bypass, but the final results were never published.30 
COSS was stopped early after an interim analysis showed 
no additional benefit with surgery compared with best 
medical treatment.31 Both studies had recruitment prob-
lems, and required PET imaging, which is expensive 
and not readily available. A subsidiary study of COSS 
also found that EC-IC bypass surgery did not improve 
cognitive function in patients with increased OEF.32 The 
study however was small, and did not evaluate quality of 
life, level of disability or mood. Nevertheless, anecdotal 
evidence suggests that EC-IC surgery may be of benefit in 
carefully selected patients with CAO and haemodynamic 
impairment benefit from revascularisation. Research eval-
uating the natural history of patients with CAO is needed.
Finally, another way to revascularise patients with CAO 
is through CAS, which has been shown to be feasible and 
practical;33 34 however, larger trials are needed to prove 
efficacy and long-term follow-up data.
MEDICAL MANAGEMENT
Conventional vascular risk factors should be addressed 
and appropriately treated. The benefit of strict blood 
pressure (BP) control in CAO and CMP is controversial. 
The loss of compensatory cerebrovascular vasodilatory 
capacity and the resultant uncoupling of cerebral auto-
regulation from systemic BP makes cerebral perfusion 
susceptible to any fall in systemic BP, especially in border-
zone regions. Aggressive BP lowering in this context may 
therefore lead to unwanted clinical outcomes.
The presence of CMP seems to modify the relationship 
between BP and stroke risk. Patients with lower BP and 
CMP had a higher stroke risk, while those with a higher BP 
without CMP had a greater stroke risk.35 In the non-sur-
gical control arm of COSS, lowering BP (<130/85) was 
associated with lower subsequent stroke risk.36 On the 
Figure 3 Patient with bilateral carotid occlusive disease 
who has had a right extracranial-intracranial bypass shunt 
surgery.
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other hand in another study, lowering BP (<130 systolic) 
was noted to increase the risk of ipsilateral stroke in those 
with CMP.37 Guidelines in the UK recommend a BP target 
of 130–150 systolic for those with ‘severe bilateral carotid 
stenosis’.38 Although CAO and severe bilateral carotid 
stenosis are not the same entities, a proportion of patients 
with the latter would have developed CMP.
OUR RECOMMENDATIONS
While we recommend liberal BP control (systolic 130–150) 
to avoid cerebral hypoperfusion, it is important to tailor 
the target BP for an individual patient according to clin-
ical response. Particular consideration should be given to 
the frequency and severity of symptoms that occur with 
lowering BP, presence of postural hypotension and the 
severity of haemodynamic impairment found on CBF 
studies. Any depletion of intravascular volume should 
be corrected, and the temporary cessation of antihyper-
tensives should be considered at times of hypovolaemia 
or expected hypovolaemia (such as during periods of 
fasting), or when on holiday in warm countries (case 
report).39
Finally, notwithstanding the unestablished benefit from 
surgical procedures to improve CBF, it is the opinion of 
the authors that certain patients may still benefit from 
revascularisation. Such patients may include those who 
are thought to be developing cognitive impairment 
related to CAO, with proven CMP from haemodynamic 
studies, and those who are relatively young with good 
baseline functional status, favourable anaesthetic risk 
profile and no life-limiting comorbidities.
CONCLUSIONS
Patients with carotid occlusive disease and CMP may 
present to multiple specialities with a wide-ranging clin-
ical phenotype, and should be considered in those with 
watershed infarcts, collapses and TIAs or episodic move-
ments associated with an orthostatic component. Early 
identification of patients with CMP may allow appropriate 
management and focus on strategies which may maintain 
or improve CBF, while avoiding potentially harmful treat-
ment.
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